TheEdgeResearch
Home / Stocks / LBTSF

Almirall, S.A. (LBTSF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$15.35 ▼ -0.78%
Market Cap
$3.34B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.18
52-Wk Range
9.01-15.47
CEO
Carlos Gallardo Piqué
Country
ES
Currency
USD

Almirall, S.A. is a biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of dermatology-focused pharmaceuticals. Its operations span Europe, the United States, and various international markets. The company provides treatments targeting a wide array of skin conditions, including actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and several orphan indications. Beyond its core dermatological focus, Almirall also extends its offerings to other therapeutic areas, such as cardiovascular, m…

Open full interactive analysis & DCF →